치열 치료 시장 규모, 점유율 및 성장 분석 : 치료법별, 적응증별, 투여 경로별, 지역별 - 업계 예측(2026-2033년)

Global Anal Fissure Treatment Market size was valued at USD 1.63 Billion in 2024 and is projected to grow from USD 1.93 Billion in 2025 to USD 7.35 Billion by 2033, expanding at a CAGR of 18.2% during the forecast period (2026-2033).

The global market for anal fissure treatment is experiencing significant expansion, fueled by rising awareness of gastrointestinal health and an uptick in anorectal disorders. Advancements in minimally invasive surgical techniques, alongside the development of novel local therapies, are broadening treatment options for patients. The integration of telemedicine and online health solutions facilitates improved access to specialist consultations, enhancing patient outcomes and satisfaction. A shift towards prioritizing quality of life and rapid recovery has led to an increase in outpatient and non-surgical methods, with therapies such as botulinum toxin injections gaining traction for their efficacy and limited recovery time. However, rising incidences of anal fissures linked to sedentary lifestyles and dietary habits correlate with heightened demand for both preventive and therapeutic interventions, compounded by concerns over patient confidentiality amidst digital health record usage.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Anal Fissure Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Anal Fissure Treatment Market Segments Analysis

The global anal fissure treatment marketis segmented into treatment type, route of administration, application, and region. By treatment type, the market is classified into topical nitroglycerin, calcium channel blockers, stool softeners, and others. Depending on the application, it is divided into clinics, hospitals, and others. According to route of administration, the market is categorized into topical and oral routes. Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Driver of the Global Anal Fissure Treatment Market

A key factor driving the growth of the anal fissure treatment market is the increasing prevalence of gastrointestinal disorders, including inflammatory bowel disease and constipation. As the number of cases rises, particularly among the elderly demographic, the occurrence of anal fissures also increases. Contributing to this trend are lifestyle and dietary factors that exacerbate gastrointestinal issues. Additionally, the aging population, which is more prone to issues such as sphincter thinning and tissue damage, will likely continue to boost the demand for affordable treatment options. This combination of factors is expected to support ongoing expansion within the market.

Restraints in the Global Anal Fissure Treatment Market

The Global Anal Fissure Treatment market faces significant challenges primarily due to inadequate awareness surrounding the symptoms and treatment options for anal fissures, particularly in emerging markets. Many healthcare providers may hesitate to refer patients due to feelings of embarrassment, a lack of understanding, or misinformation regarding the condition. This results in a cycle of underdiagnosis and insufficient treatment, with cases often progressing into chronic stages that require more complex and expensive interventions. Additionally, limited public education initiatives and the availability of suitable healthcare facilities in specific areas further hinder timely intervention, restricting market access and growth opportunities.

Market Trends of the Global Anal Fissure Treatment Market

The Global Anal Fissure Treatment market is witnessing a significant shift towards minimally invasive procedures and advanced therapeutic options, reflecting a growing preference among both physicians and patients. This trend emphasizes a movement away from traditional surgical interventions, with an increasing adoption of treatments such as botulinum toxin injections, innovative topical medications, and enhanced drug delivery systems. These modern therapies offer benefits such as quicker recovery times, lower incidences of adverse effects, and enhanced convenience for patients, ultimately leading to improved compliance and satisfaction. This evolution in treatment modalities is poised to reshape the landscape of anal fissure management significantly.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Anal Fissure Treatment Market Size by Treatment Types & CAGR (2026-2033)

• Market Overview
• Topical Nitroglycerin
• Calcium channel Blockers
• Stool Softeners
• Other

Global Anal Fissure Treatment Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinics
• Hospitals
• Other

Global Anal Fissure Treatment Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Topical
• Oral Routes

Global Anal Fissure Treatment Market Size & CAGR (2026-2033)

• North America (Treatment Types, Application, Route of Administration)
  • US
  • Canada
• Europe (Treatment Types, Application, Route of Administration)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Types, Application, Route of Administration)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Types, Application, Route of Administration)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Types, Application, Route of Administration)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Cipla Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geri-Care Pharmaceuticals Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Troikaa Pharmaceuticals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RDD Pharma Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyowa Kirin Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ipsen Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bliss GVS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SRS Life Sciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Healthy Life Pharma Private Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations